ICD-10 Coding for Diffuse Large B-Cell Lymphoma(C83.3, C83.39)
Complete ICD-10-CM coding and documentation guide for Diffuse Large B-Cell Lymphoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Diffuse Large B-Cell Lymphoma
C83.3-C83.39Primary Range
Diffuse large B-cell lymphoma codes
This range covers the primary codes for diffuse large B-cell lymphoma, including site-specific and remission codes.
Personal history of non-Hodgkin lymphoma
Used when the lymphoma is in remission and no longer active.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C83.3 | Diffuse large B-cell lymphoma | Use for confirmed cases of DLBCL with specified site. |
|
| C83.39 | Diffuse large B-cell lymphoma, extranodal and solid organ sites | Use when DLBCL is confirmed in extranodal sites. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for diffuse large B-cell lymphoma
Essential facts and insights about Diffuse Large B-Cell Lymphoma
Primary ICD-10-CM Codes for brother cell lymphoma
Decision Criteria
clinical Criteria
- Biopsy-confirmed DLBCL with specific immunophenotyping
Applicable To
- DLBCL of lymph nodes
Clinical Validation Requirements
- Biopsy-confirmed DLBCL
- Immunophenotyping showing CD20+
Code-Specific Risks
- Confusion with other lymphomas if site not specified
Coding Notes
- Ensure site is specified to avoid miscoding.
C83.39 - Diffuse large B-cell lymphoma, extranodal and solid organ sites
Use when DLBCL is confirmed in extranodal sites.
Applicable To
- DLBCL involving organs like lung, liver, CNS
Clinical Validation Requirements
- Imaging or biopsy confirmation of organ involvement
Coding Notes
Ensure organ involvement is documented.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Personal history of non-Hodgkin lymphoma
Z85.81Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Diffuse Large B-Cell Lymphoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C83.3.
Impact
Clinical: Impacts treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for incorrect billing.
Mitigation Strategy
Review pathology reports for site details, Educate staff on documentation standards
Impact
Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation Strategy
Use C83.39 for extranodal involvement instead of secondary site codes.
Impact
Lack of site documentation can lead to audit findings.
Mitigation Strategy
Ensure all documentation includes specific site details.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Diffuse Large B-Cell Lymphoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Diffuse Large B-Cell Lymphoma
Use these documentation templates to ensure complete and accurate documentation for Diffuse Large B-Cell Lymphoma. These templates include all required elements for proper coding and billing.
Oncology Progress Note
Specialty: OncologyRequired Elements
- Subjective symptoms
- Objective findings
- Assessment
- Plan
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Diffuse Large B-Cell Lymphoma? Ask your questions below.